MeiraGTx CEO on Potential of Gene Therapy, Innovation

The video discusses gene therapy as a new treatment modality, highlighting its initial high costs and the steps taken to reduce them, such as in-house manufacturing. It explores the impact of COVID-19 on healthcare, emphasizing the role of new technologies and vaccines. The future of gene therapy is promising, with advancements expected in treating inherited diseases and other conditions. The video also touches on the sophisticated biotech investment ecosystem, particularly in the US.

What was one of the initial challenges faced by gene therapy companies?

• Insufficient clinical trials

• Limited patient interest

• High manufacturing costs

• Lack of regulatory approval

How did the COVID-19 pandemic influence the perception of healthcare technologies?

• It shifted focus entirely to vaccines.

• It highlighted the need for new treatments for non-infectious diseases.

• It reduced investment in biotech.

• It led to a decrease in healthcare innovation.

Which diseases are mentioned as potential targets for future gene therapy applications?

• Arthritis and osteoporosis

• Asthma and allergies

• Diabetes and brain cancer

• Common cold and flu

What is the expected timeline for gene therapy to address diseases like diabetes and brain cancer?

• In 4 to 5 years

• In about 10 years

• It is already available

• Within the next year

Where is the most sophisticated healthcare and biotech investment ecosystem located?

• Australia

• United States

• Asia

• Europe